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Type 1 autoimmune pancreatitis: relapse with 
liver abscess
Pancreatite autoimune tipo 1: recidiva com abscesso hepático
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epigastric	 pain	 radiating	 to	 the	 back,	 associated	with	 jaundice,	 xerostomia,	 nausea,	 and	 vomiting,	 since	 2014,	
diagnosed	two	years	 later	with	an	unresectable	pancreatic	adenocarcinoma.	The	diagnosis	was	questioned	after	
a	few	follow-up	months	without	clinical	deterioration	when	it	was	suggested	the	possibility	of	type	1	autoimmune	









64	anos,	que	apresentou	quadros	 recorrentes	de	dor	epigástrica	 com	 irradiação	para	as	 costas,	 associada	 com	
icterícia,	xerostomia,	náuseas	e	vômitos	desde	2014,	diagnosticado	após	2	anos	com	adenocarcinoma	pancreáti-











IgG4-related	 disease	 (IgG4-RD),	 also	
known	 as	 IgG4-related	 Sclerosing	 Disease,	 is	 a	
recently	 defined	 entity	 characterized	 by	 serum	
elevated	levels	of	IgG4,	lymphoplasmacytic	infil-
trate	and	an	immune-mediated	fibroinflammatory	
process in the organs affected. This is a systemic 
disease associated with pancreatic impairment 
recognized	 as	 Type	 1	 Autoimmune	 Pancreatitis	
(AIP),	 a	 rare	 form	 of	 chronic	 pancreatitis.	 This	





frequent alcohol use since the age of 12, was ad-
mitted	to	a	tertiary	referral	hospital	in	July	2016	 
reporting severe epigastric pain radiating to the 
back,	associated	with	jaundice,	xerostomia,	nau-
sea,	 and	 vomiting,	 since	 the	 middle	 of	 2014.	 
He	 also	 reported	 weight	 loss	 of	 about	 16	 kilo-
grams	(kg)	in	this	period	(standard	weight	64	kg)	
despite a well-preserved appetite. There was no 
evidence	 of	 fever,	 steatorrhea,	 change	 in	 bowel	
habits,	 gastrointestinal	 bleeding,	 ascites,	 lym-
phadenopathy or hepatosplenomegaly.
A	 computed	 tomography	 (CT)	 scan	 of	 the	
abdomen	 was	 performed	 which	 revealed	 pan-
creatic parenchymal alteration, more evidently 
seen in the region of the head (Image 1). In that 
tertiary center, the surgical treatment was then 
indicated since the initial diagnostic hypothesis 
was pancreatic adenocarcinoma. Due to the in-
traoperative	definition	of	the	unresectable	lesion,	
biliodigestive	derivation	and	gastrojejunal	bypass	
were performed. The anatomopathological result 
was negative for neoplastic cells and the material 
was	 compatible	 with	 fibro-neutrophilic	 exudate.	
Levels	 of	 CA	 19.9	 and	 CEA	 were	 normal	 in	 the	
outpatient	 follow-up.	 Due	 to	 these	 findings,	 the	
patient was referred to the Gastroenterology De-
partment of the Walter Cantídio University Hospi-
tal for further investigation.
Image 1: A computed tomography (CT) scan revealed an ex-
pansive and infiltrative formation in the head of the pancreas 
with a cystic component. It also showed pancreatic calculi, 
irregular dilatation of the main pancreatic duct, and splenic 
and superior mesenteric vein thrombosis.
The patient was admitted to the Gastroente-
rology Unit, where it was suggested the diagnos-
tic	 hypothesis	 of	 Autoimmune	 Pancreatitis	 type	 1,	 
IgG4-related,	due	to	 the	possibility	of	a	pseudotu-




(Normal	 range:	 8-140	 mg/dL)	 and	 it	 was	 started	
prednisone in therapeutic dosage. During the follow-
-up, slow glucocorticoid weaning was then perfor-
med.	It	was	prescribed	pancreatic	enzymes,	calcium,	
and D vitamin. Empirical treatment with antiparasitic 
drugs was performed due to the high prevalence of 
parasitosis in our region and due to the immunosu-
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ppressive therapy. Bone densitometry was required. 
An	immunohistochemical	analysis	of	the	intraopera-
tive	 fragment	was	 performed.	 In	November	 2016,	
the	patient	presented	for	the	first	time	high	fasting	




During hospitalization, the insulin regimen 
was	adjusted	and	the	corticoid	dosage	was	decre-
ased.	 A	 new	 abdominal	 CT	 scan	 was	 performed,	
which revealed maintenance of diffuse involvement 
pattern of the pancreas, suggestive of chronic pan-
creatitis.	Also,	contrast-enhanced	tomography	of	the	
salivary glands has demonstrated highly suggestive 
findings	of	Sclerosing	Sialadenitis	 related	 to	 IgG4	
Disease. However, the immunohistochemical analy-
sis	of	the	intraoperative	fragment	of	the	July	2016	 
pancreatic	biopsy	was	performed	and	revealed	the	
absence	 of	 IgG4.	 Nevertheless,	 it	 was	 described	
that the sample contained scarce material, recom-
mending a new sample for histological revaluation.
After	discharge	from	the	hospital,	the	patient	
maintained	 an	 outpatient	 follow-up	 every	 4	mon-
ths, and the corticosteroid weaning was performed 
progressively. He remained asymptomatic with pe-
riodic follow-up and prednisone was discontinued 
after	about	a	year	and	a	half	 of	 the	beginning	of	
corticotherapy.	 In	October	 2018,	 the	 patient	 pre-
sented with new tomographic imaging (Image 2) 
that	 confirmed	 therapeutic	 response.	 However,	
it	 was	 observed	 an	 asymptomatic	 hepatic	 abs-
cess, which motivated a new hospitalization for 
further evaluation.
Image 2: A computed tomography (CT) scan that showed a volumetric reduction of the pancreatic head with splenic vein recanalization.
Abdominal	 Magnetic	 Resonance	 Imaging	
(MRI) and Magnetic Resonance Cholangiopancre-
atography	were	performed	(Images	3	and	4)	and	
a	 massive	 hepatic	 abscess	 was	 observed.	 There	
were	 also	 described	 areas	 of	 discontinuous	 nar-
rowing	of	the	intrahepatic	bile	ducts	suggestive	of	
sclerosing cholangitis. During hospitalization, he 
denied	fever,	weight	loss,	jaundice,	loss	of	appeti-
te	or	abdominal	pain.	The	abscess	was	successfully	
treated with percutaneous drainage and antimicro-
bial	therapy	(ciprofloxacin	and	metronidazole)	for	
six	weeks.	At	the	time	of	presenting	this	case	re-
port, he remained asymptomatic with no hepatic 
collection	observed	in	control	ultrasonography	and	
is using azathioprine as maintenance therapy, with 
good tolerance and no drug-related side effects. 
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Image 3: Abscess in the VIII liver segment measuring 8.2 x 
6.0 x 5.2 cm shown in (a) axial T2-weighted and (b) Fat-satu-
rated post gadolinium coronal T1-weighted Abdominal MRI.
Image 4: Magnetic Resonance Cholangiopancreatography 
that revealed discontinuous narrowing of the intrahepatic bile 
ducts, with predominantly central involvement.
DISCUSSION
AIP	is	a	rare	disorder	characterized	by	lym-
phoplasmacytic	 infiltrate	 and	 fibrosis	 in	 the	 pan-
creas and a very good response to steroids1. 
It predominantly affects men during the seventh 




mass, recurrent pancreatitis, pancreatic duct stric-
ture and symptoms related to systemic diseases3. 
It	 can	 be	 divided	 into	 two	 types,	 each	 one	 with	
its diagnostic criteria4. Type 1, the most common2, 
is	 histologically	 characterized	 by	 periductal	 plas-
ma	 and	 lymphocytes	 infiltrate,	 “storiform”	 fibro-
sis,	obliterative	phlebitis,	and	great	infiltration	by	
IgG4+	 plasma	 cells	 (>10	 cells	 per	 higher-power	
field)1,4. This histologic description is called Lym-
phoplasmacytic sclerosing pancreatitis (LPSP) or 
AIP	 without	 granulocyte	 epithelial	 lesions	 (GEL).	
It is considered a pancreatic manifestation of Ig-
G4-related	 disease	 (elevated	 serum	 IgG4	 levels	




ally affects younger patients6.
Several	 diagnostic	 criteria	 for	 AIP	 were	
proposed	 from	 various	 countries	 between	 2002	 
and 2009. These diagnostic criteria varied re-
flecting	 the	 differences	 in	 the	 diagnostic	 appro-
ach and patient population (proportion of type 
1	 and	 type	 2	 AIP).	 The	 International	 Consen-
sus	Diagnostic	Criteria	(ICDC)	 for	AIP1 were de-
signed to make diagnostic evaluation less rigid 
and	 acknowledge	 the	 two	 AIP	 subtypes.	 It	 is	 a	
complex	 criteria	 based	 on	 the	 five	 cardinal	 fea-
tures	 of	 AIP:	 (1)	 imaging	 features	 of	 pancre-
atic parenchyma (CT, MRI) and pancreatic duct 
(endoscopic retrograde cholangiopancreatogra-
phy or magnetic resonance cholangiopancrea-
tography),	 (2)	 serology	 (IgG4,	 IgG,	and	antinu-
clear	 antibody),	 (3)	 other	 organ	 involvement,	 
(4)	histopathology	of	the	pancreas,	and	(5)	res-
ponse to steroid therapy.





1. Histology: LPSP or lymphoplasmacytic infiltrate 
with storiform fibrosis showing abundant IgG4-po-
sitive cells.
2. Typical pancreatic imaging: diffusely enlarged 
gland with delayed enhancement; diffusely irre-
gular, attenuated main pancreatic duct. 
3. Serology: elevated serum IgG4 level (normal 
8–140 mg/dL).
4. Other organ involvement: hilar/intrahepatic biliary 
strictures, persistent distal biliary stricture, paro-
tid/lacrimal gland involvement, mediastinal lym-
phadenopathy, retroperitoneal fibrosis.
5. Response to steroid treatment.
These	categories	are	then	combined	to	form	
three	 distinct	 diagnostic	 groups:	 Group	 A	 (diag-
nostic pancreatic histology), Group B (typical ima-
ging	+	serology),	and	Group	C	(response	to	ste-
roids)7. Following these criteria, our patient met 
the	diagnostic	of	AIP	according	to	his	response	to	
steroids,	associated	with	elevated	serum	IgG4.






nosis of autoimmune pancreatitis, analyzing 29 
cases	 of	 AIP.	 There	 was	 moderate	 to	 marked	
staining in 21 of 29 cases, with only one case 
presenting	 no	 IgG4-positive	 plasma	 cell	 infiltra-
tion. That study found that there were increased 
numbers	of	pancreatic	IgG4-positive	plasma	cells	
in	AIP	compared	to	chronic	alcoholic	pancreatitis	
and pancreatic ductal adenocarcinoma. However, 
in	our	case,	the	results	of	the	biopsy	and	its	IgG4	
staining	 should	 be	 questioned,	 considering	 that	
the sample contained scarce material8.
One	of	the	obstacles	to	obtaining	the	diag-
nosis	was	the	resemblance	of	 the	 imaging	of	 the	
AIP	with	 pancreatic	 adenocarcinoma.	 AIP	 can	 be	
divided	 into	 two	 forms:	 diffuse	 or	 localized.	 The	
focal	form	of	AIP,	also	called	pseudotumoral	form,	
can present as a pancreatic mass and therefore 
can mimic an adenocarcinoma. The distinction 
between	these	two	entities	is	important	since	the	
treatment approach and prognosis are quite dif-
ferent.	Obstructive	jaundice,	weight	loss,	and	ab-
dominal	 pain	 are	 clinical	 features	 of	 both.	 Some	
findings	 in	 MRI	 and	 Diffusion-Weighted	 MRI	 are	
more	frequently	seen	in	AIP,	thus	can	help	to	dis-
tinguish	it	from	cancer:		similar	or	high	signal	in-
tensity on portal phase and 3- and 20-minute de-
layed phase images, homogeneous enhancement, 
no	peripancreatic	fat	infiltration,	no	internal	cystic	
or necrotic portion, capsule-like rim, no upstream 
pancreatitis, no vascular invasion, and duct pe-
netrating sign9,10. Serologically, elevated levels of 
IgG4	favors	the	diagnosis	of	AIP.	While	the	patient	
had a cystic component on CT, 2-year presentation 
moves away from the hypothesis of cancer.
Another	diagnostic	barrier	was	the	overlap	
between	AIP	and	alcoholic	pancreatitis.	The	pre-
sence of heavy alcohol consumption, duct dila-
tion,	and	pancreatic	calcifications	on	CT	in	our	pa-
tient could suggest alcohol-induced pancreatitis, 
although there is no peripancreatic fat necrosis 
and pseudocyst formation, which is often seen in 
alcohol etiology. Besides, the high levels of serum 
IgG4,	 good	 response	 to	 steroids,	 and	 extrapan-





glands, kidneys, retroperitoneum, and lungs. Be-
sides	 AIP,	 the	 current	 patient	 presented	 clinical	
and	radiological	findings	suggestive	of	Sclerosing	
Sialadenitis	 related	 to	 IgG4	Disease,	which	con-
tributes	 to	 the	 systemic	diagnosis	of	 IgG4-RD12. 




shares similar clinical features with Primary Scle-
rosing	 Cholangitis	 (PSC).	 While	 the	 majority	 of	
patients of PSC is diagnosed asymptomatic, the 
most	 frequent	 symptom	 reported	 in	 IgG4-SC	 is	
jaundice	and	clinical	presentation	of	cholestasis,	
with	IgG4-SC	being	more	acute	and	of	a	shorter	
duration14,15. Tokala et al16 proposed MRI imaging 
findings	 that	 favor	 IgG4-SC	 to	 help	 distinguish	









and good response to steroids17. In this case, the 
biliary	disease	was	relatively	long,	differing	from	
the	classical	beaded	PSC	appearance.




-up with clinical analysis and imaging studies is 
strongly recommended15.
Besides, our patient developed a pyogenic 
liver	 abscess.	 The	main	 causes	 of	 bacterial	 liver	
abscesses	are	biliary	tract	diseases,	such	as	chole-
docholithiasis,	obstructing	tumors,	strictures,	and	








lution was due to the treatment with steroids. In 





AIP	 is	 a	 known	 complication	 of	 IgG4-RD,	
whose	diagnosis	should	be	suspected	in	patients	
with	unexplained	pancreatic	mass	and	it	is	an	im-
portant diagnostic consideration due to the con-
sequences of a misconducted case as pancreatic 
adenocarcinoma, including aggressive surgical 
approach.	It	commonly	presents	as	painless	obs-
tructive	jaundice	in	old	males	and	may	be	accom-
panied	 by	 other	 organ	 involvement	 or	 systemic	
symptoms.	The	confirmatory	diagnosis	may	be	di-
fficult	to	establish	and	clinical	presentation	can	be	
quite	 variable.	 Immunohistology	 results	 are	 not	
always	compatible.	Recently,	the	Mayo	Clinic	pro-
posed diagnostic criteria to support it. This case 
report	presented	an	AIP	with	a	seldom	reported	
association	 of	 IgG4-SC	 and	 pyogenic	 liver	 abs-




Work developed in Hospital Universitário 
Walter Cantídio, Fortaleza, CE, Brazil.
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